BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32140907)

  • 21. Evaluation of CRISPR gene-editing tools in zebrafish.
    Uribe-Salazar JM; Kaya G; Sekar A; Weyenberg K; Ingamells C; Dennis MY
    BMC Genomics; 2022 Jan; 23(1):12. PubMed ID: 34986794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling Genome-Wide Specificity of CRISPR-Cas9 Using Digenome-Seq.
    Kim D; Kim JS
    Methods Mol Biol; 2021; 2162():233-242. PubMed ID: 32926386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid genome editing by CRISPR-Cas9-POLD3 fusion.
    Reint G; Li Z; Labun K; Keskitalo S; Soppa I; Mamia K; Tolo E; Szymanska M; Meza-Zepeda LA; Lorenz S; Cieslar-Pobuda A; Hu X; Bordin DL; Staerk J; Valen E; Schmierer B; Varjosalo M; Taipale J; Haapaniemi E
    Elife; 2021 Dec; 10():. PubMed ID: 34898428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas9-Mediated Genome Editing of Trichoderma reesei.
    Zou G; Zhou Z
    Methods Mol Biol; 2021; 2234():87-98. PubMed ID: 33165782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNAzyme activated protein-scaffolded CRISPR-Cas9 nanoassembly for genome editing.
    Zhu X; Lv MM; Liu JW; Yu RQ; Jiang JH
    Chem Commun (Camb); 2019 Jun; 55(46):6511-6514. PubMed ID: 31099367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system.
    Yin L; Maddison LA; Chen W
    Methods Cell Biol; 2016; 135():3-17. PubMed ID: 27443918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods for Measuring CRISPR/Cas9 DNA Cleavage in Cells.
    Cromwell CR; Jovel J; Hubbard BP
    Methods Mol Biol; 2021; 2162():197-213. PubMed ID: 32926384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of Cas9 transgenic zebrafish and their application in establishing an ERV-deficient animal model.
    Yang Z; Chen S; Xue S; Li X; Sun Z; Yang Y; Hu X; Geng T; Cui H
    Biotechnol Lett; 2018 Dec; 40(11-12):1507-1518. PubMed ID: 30244429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The zebrafish genome editing toolkit.
    Ata H; Clark KJ; Ekker SC
    Methods Cell Biol; 2016; 135():149-70. PubMed ID: 27443924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome editing in plants by engineered CRISPR-Cas9 recognizing NG PAM.
    Endo M; Mikami M; Endo A; Kaya H; Itoh T; Nishimasu H; Nureki O; Toki S
    Nat Plants; 2019 Jan; 5(1):14-17. PubMed ID: 30531939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Directed Evolution of CRISPR-Cas9 Base Editors.
    Winter J; Perez-Pinera P
    Trends Biotechnol; 2019 Nov; 37(11):1151-1153. PubMed ID: 31623959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9 genome editing throws descriptive 3-D genome folding studies for a loop.
    Beagan JA; Phillips-Cremins JE
    Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):286-99. PubMed ID: 27265842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New advances in CRISPR/Cas-mediated precise gene-editing techniques.
    Richardson C; Kelsh RN; J Richardson R
    Dis Model Mech; 2023 Feb; 16(2):. PubMed ID: 36847161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
    Hohmann S
    Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
    [No Abstract]   [Full Text] [Related]  

  • 36. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM.
    Liu Y; Liang F; Dong Z; Li S; Ye J; Qin W
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Assays for Comparing the Specificity of First- and Next-Generation CRISPR/Cas9 Systems.
    Cromwell CR; Hubbard BP
    Methods Mol Biol; 2021; 2162():215-232. PubMed ID: 32926385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.